Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome.
Saved in:
| Title: | Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome. |
|---|---|
| Authors: | Talbot A; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris. alexis.talbot@aphp.fr., Forgeard N; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Vaugeois T; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Theves F; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Dimassi S; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Royer B; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Debureaux PE; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Meignin V; Department of Pathology, Saint-Louis Hospital, AP-HP, Paris., Vercellino L; Université Paris Cité, Paris, France; Department of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris., Boutboul D; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris., Arnulf B; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris., Harel S; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris. |
| Source: | Haematologica [Haematologica] 2026 Apr 01; Vol. 111 (4), pp. 1490-1493. Date of Electronic Publication: 2025 Jul 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40605704 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Talbot+A%22">Talbot A</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris. alexis.talbot@aphp.fr.<br /><searchLink fieldCode="AU" term="%22Forgeard+N%22">Forgeard N</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Vaugeois+T%22">Vaugeois T</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Theves+F%22">Theves F</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Dimassi+S%22">Dimassi S</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Royer+B%22">Royer B</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Debureaux+PE%22">Debureaux PE</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Meignin+V%22">Meignin V</searchLink>; Department of Pathology, Saint-Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Vercellino+L%22">Vercellino L</searchLink>; Université Paris Cité, Paris, France; Department of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22Boutboul+D%22">Boutboul D</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris.<br /><searchLink fieldCode="AU" term="%22Arnulf+B%22">Arnulf B</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris.<br /><searchLink fieldCode="AU" term="%22Harel+S%22">Harel S</searchLink>; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2026 Apr 01; Vol. 111 (4), pp. 1490-1493. <i>Date of Electronic Publication: </i>2025 Jul 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40605704 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3324/haematol.2025.287606 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1490 Titles: – TitleFull: Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Talbot A – PersonEntity: Name: NameFull: Forgeard N – PersonEntity: Name: NameFull: Vaugeois T – PersonEntity: Name: NameFull: Theves F – PersonEntity: Name: NameFull: Dimassi S – PersonEntity: Name: NameFull: Royer B – PersonEntity: Name: NameFull: Debureaux PE – PersonEntity: Name: NameFull: Meignin V – PersonEntity: Name: NameFull: Vercellino L – PersonEntity: Name: NameFull: Boutboul D – PersonEntity: Name: NameFull: Arnulf B – PersonEntity: Name: NameFull: Harel S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1592-8721 Numbering: – Type: volume Value: 111 – Type: issue Value: 4 Titles: – TitleFull: Haematologica Type: main |
| ResultId | 1 |